Stem Cell Transplantation
Poor mobilization predicts survival in PBSCT-treated non-Hodgkin lymphoma
Published in Cancer Weekly, June 5th, 2006
According to a recently published study from Italy, "Hematopoietic stem cell therapy is an increasingly adopted procedure in the treatment of patients with malignant lymphoma.
"In this retrospective analysis, we evaluated 262 patients, 57 (22%) with Hodgkin's and 205 (78%) with non-Hodgkin's lymphomas (NHL), and 665 harvesting procedures in order to assess the impact of poor mobilization on survival and to determine the factors that may be predictive of CD34+ poor mobilization."
"The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-06-05)
More Articles from Cancer Weekly
- Complementary & Alternative Medicine
Cancer therapy efficacy increased by controlling meal timing - Leukemia
Leukemia may be treated by novel polycyclic aromatic hydrocarbons - Skin Cancer
Public health skin cancer prevention policies should prohibit UV tanning advertising to minors - Uveal Melanoma
Uveal melanoma imaging improved with a 3.0-T MRI using a surface coil - Allergy & Immunology
Rheumatoid arthritis drug linked to serious infections and cancers - Anal Cancer
Elevated anal squamous cell carcinoma risk linked to benign inflammatory anal lesions - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
